Physiogenex Overview

  • Year Founded
  • 2003

Year Founded

  • Status
  • Private

  • Employees
  • 21

Employees

  • Latest Deal Type
  • 2ndary - Private

  • Investors
  • 3

Physiogenex General Information

Description

Provider of preclinical research services intended for animal models of obesity and related co-morbidities. The company specializes in research and consulting activities relating to metabolic disorders like obesity, fatty liver, and atherosclerosis as well as develops innovative models for all metabolic diseases and their complications, enabling pharmaceutical, biotechnology, and nutraceutical companies to optimize preclinical drug candidates' studies and reduce the cost and time.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Formerly Accelerator/Incubator backed
Primary Industry
Other Healthcare Services
Other Industries
Hospitals/Inpatient Services
Corporate Office
  • 280 Rue De L'hers
  • ZAC de la Masquère
  • 31750 Escalquens
  • France
+33 05 00 00 00 00

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Physiogenex Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Secondary Transaction - Private Completed Generating Revenue
3. Angel (individual) Completed Generating Revenue
2. Grant Completed Generating Revenue
1. Accelerator/Incubator Completed Generating Revenue
To view Physiogenex’s complete valuation and funding history, request access »

Physiogenex Executive Team (3)

Name Title Board Seat Contact Info
Thierry Sulpice Ph.D Co-Founder, President, Chief Executive Officer, Chief Scientific Officer, Chairman & Member of the Scientific Advisory Board
Remy Burcelin Ph.D Co-Founder, President & Chairman of the Scientific Advisory Board
François Briand Ph.D Director of Research and Business Development & Member of the Scientific Advisory Board
To view Physiogenex’s complete executive team members history, request access »

Physiogenex Board Members (3)

Name Representing Role Since
François Briand Ph.D Physiogenex Director of Research and Business Development & Member of the Scientific Advisory Board 000 0000
Remy Burcelin Ph.D Physiogenex Co-Founder, President & Chairman of the Scientific Advisory Board 000 0000
You’re viewing 2 of 3 board members. Get the full list »

Physiogenex Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Physiogenex Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
European Regional Development Fund (FEDER) Government 000 0000 000000 0
L'Agence Nationale de la Recherche Government 000 0000 000000 0
OSEO Innovation Venture Capital Minority 000 0000 000000 0
To view Physiogenex’s complete investors history, request access »

Physiogenex FAQs

  • When was Physiogenex founded?

    Physiogenex was founded in 2003.

  • Who is the founder of Physiogenex?

    Thierry Sulpice Ph.D and Remy Burcelin Ph.D are the founders of Physiogenex.

  • Who is the CEO of Physiogenex?

    Thierry Sulpice Ph.D is the CEO of Physiogenex.

  • Where is Physiogenex headquartered?

    Physiogenex is headquartered in Escalquens, France.

  • What is the size of Physiogenex?

    Physiogenex has 21 total employees.

  • What industry is Physiogenex in?

    Physiogenex’s primary industry is Other Healthcare Services.

  • Is Physiogenex a private or public company?

    Physiogenex is a Private company.

  • What is Physiogenex’s current revenue?

    The current revenue for Physiogenex is 000000.

  • Who are Physiogenex’s investors?

    European Regional Development Fund (FEDER), L'Agence Nationale de la Recherche, and OSEO Innovation have invested in Physiogenex.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »